Drug & medication recalls Moderate risk

Vancomycin Hydrochloride for Injection recalled over temperature-control failures

Recall date
October 6, 2014
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Hospira Inc. recalls Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, R…
Recall number
D-0387-2015
FDA classification
Class II
Brand / firm
Hospira Inc.
Sold / distributed
Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribut…

Why it was recalled

Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4332-01.

Get recall alerts

Free email alert whenever Hospira Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Hospira Inc.